SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-19-000054
Filing Date
2019-08-20
Accepted
2019-08-20 16:17:03
Documents
2
Period of Report
2019-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156633220629149.html 4  
1 FORM 4 wf-form4_156633220629149.xml 4 3964
2 POA - BURGESS poa-burgess.htm EX-24 3327
  Complete submission text file 0001447028-19-000054.txt   8847
Mailing Address C/O HOLLIS-EDEN PHARMACEUTICALS 4435 EASTGATE MALL STE.400 SAN DIEGO CA 92121
Business Address
BURGESS DANIEL D (Reporting) CIK: 0001239650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 191039695

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations